Research & Development
Next-generation sequencing can help diagnose T-cell lymphoma
"We suggest a testing strategy using t-NGS as the primary test, followed by TCR [T-cell receptor] clonality analysis if negative," wrote the authors, led by Charlotte Syrykh of the pathology department at the Cancer University Institute of Toulouse-Oncopole in Toulouse, France.
November 18, 2021
Fosun Kite announces CAR T-cell therapy approval
The therapy is for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.
June 24, 2021
CAP, ASCP release lymphoma workup guide
The guidelines focus on lymphoma diagnosis using samples from fine-needle aspirations or needle biopsies, and the increasing need to perform additional tests to identify lymphoma subtypes.
November 11, 2020
Roche wins FDA nod for follicular lymphoma mutation test
A companion diagnostic for patients with follicular lymphoma, Roche's new cobas test detects mutations in the EZH2 gene in follicular lymphoma patients who may be eligible for treatment with the drug tazemetostat (Epizyme's Tazverik), which acts as a selective EZH2 gene inhibitor.
June 22, 2020
AbbVie to deploy Adaptive's clonoSeq test in myeloma trials
Venclexta is currently approved by the U.S. Food and Drug Administration (FDA) for use in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, and in older patients with newly diagnosed acute myeloid leukemia who can't tolerate intensive chemotherapy. It is being tested for a number of additional indications, including multiple myeloma.
December 8, 2019
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
Page 1 of 1